High efficacy of sofosbuvir/velpatasvir plus GS-9857 for 12 weeks in treatment-experienced genotype 1-6 hcvinfected patients, including those previously treated with direct-acting antivirals

Authors
Category Primary study
JournalJournal of Hepatology
Year 2016
This article has no abstract
Epistemonikos ID: 30912a6864bc4c0fcae7cee553ecbc3dcdbc3841
First added on: Feb 07, 2025